Vol 2, No 5 (2015)

Table of Contents


Cardiovascular benefits and risk profiles of oral anti-diabetic agents: current evidence and ongoing trials PDF HTML
Yi-Cheng Chang, Juey-Jen Hwang, Shih-Che Hua 386-392
The Role of PCSK9 in Lipid Metabolism: Clinical Relevance to Treating Cardiac Disease PDF HTML
Yipin Han, Monte S. Willis 393-399
The Role of Cardiac Biomarkers in Predicting of Mortality in Diabetic Patients PDF HTML
Alexander E. Berezin 400-404


Statins and Heart Failure PDF HTML
Juan J. Chillarón, David Benaiges, Elisenda Climent, Juana A. Flores-Le Roux, Juan Pedro-Botet 405-409
Bedside Echocardiography In Patients With Hip Fracture PDF HTML
Carlo Rostagno 410-413
Electrocardiographic Features in the Diagnosis and Risk Assessment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia PDF HTML
Stefan Stefan Peters 141-417
2015 Guidelines on Treatment of Hypertension in Patients With Coronary Artery Disease PDF HTML
Wilbert S. Aronow 418-421
New Clinical Trials With Evolocumab and Alirocumab on Cardiovascular Outcomes, in Patients With High Rsk of Acute Coronary Syndromes PDF HTML
Singh RB, Krasimira Hristova, Jan Fedacko, Galal Elkilany, Narsingh Verma 422-424
Can Prevention of Low Birth Weight in Newborn may be Associated with Primordial Prevention of Cardiovascular Diseases and Type 2 Diabetes in Adult Life? PDF HTML
RB Singh, Banshi Saboo, Anuj Maheshwari, Poonam Singh, NS Verma, Shantanu Singhal, Zubin Pradeep Sharma 425-429

Original Article

Clinical Outcomes of Pharmaco-invasive ST-elevation Myocardial Infarction Management in a Large Australian Regional Centre PDF HTML
Bo Xu, Voltaire Nadurata, Kate Avery, Charles Chilvers, Shelene Laiu 430-435

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

ISSN: 2312-122X